- Home
- ZEUS vs GHRS Comparison
ZEUS vs GHRS Comparison
Compare ZEUS & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEUS
- GHRS
- Stock Information
- Founded
- ZEUS 1954
- GHRS 2018
- Country
- ZEUS United States
- GHRS Ireland
- Employees
- ZEUS N/A
- GHRS N/A
- Industry
- ZEUS Metal Fabrications
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- ZEUS Industrials
- GHRS Health Care
- Exchange
- ZEUS Nasdaq
- GHRS Nasdaq
- Market Cap
- ZEUS 406.7M
- GHRS 402.7M
- IPO Year
- ZEUS 1994
- GHRS 2021
- Fundamental
- Price
- ZEUS $39.34
- GHRS $8.15
- Analyst Decision
- ZEUS
- GHRS Strong Buy
- Analyst Count
- ZEUS 0
- GHRS 3
- Target Price
- ZEUS N/A
- GHRS $35.67
- AVG Volume (30 Days)
- ZEUS 107.1K
- GHRS 55.0K
- Earning Date
- ZEUS 10-31-2024
- GHRS 11-14-2024
- Dividend Yield
- ZEUS 1.57%
- GHRS N/A
- EPS Growth
- ZEUS N/A
- GHRS N/A
- EPS
- ZEUS 2.27
- GHRS N/A
- Revenue
- ZEUS $2,012,296,000.00
- GHRS N/A
- Revenue This Year
- ZEUS N/A
- GHRS N/A
- Revenue Next Year
- ZEUS $5.62
- GHRS N/A
- P/E Ratio
- ZEUS $16.80
- GHRS N/A
- Revenue Growth
- ZEUS N/A
- GHRS N/A
- 52 Week Low
- ZEUS $32.23
- GHRS $5.08
- 52 Week High
- ZEUS $73.49
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- ZEUS 40.83
- GHRS 49.34
- Support Level
- ZEUS $40.52
- GHRS $7.29
- Resistance Level
- ZEUS $42.98
- GHRS $10.00
- Average True Range (ATR)
- ZEUS 1.34
- GHRS 0.83
- MACD
- ZEUS -0.47
- GHRS -0.09
- Stochastic Oscillator
- ZEUS 6.88
- GHRS 43.17
About ZEUS Olympic Steel Inc.
Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.